FI894546A0 - Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi

Info

Publication number
FI894546A0
FI894546A0 FI894546A FI894546A FI894546A0 FI 894546 A0 FI894546 A0 FI 894546A0 FI 894546 A FI894546 A FI 894546A FI 894546 A FI894546 A FI 894546A FI 894546 A0 FI894546 A0 FI 894546A0
Authority
FI
Finland
Prior art keywords
ethynyladenosine
ethenylidene
derivatives
preparation
new
Prior art date
Application number
FI894546A
Other languages
English (en)
Swedish (sv)
Other versions
FI94763C (fi
FI94763B (fi
FI894546A (fi
Inventor
James R Mccarthy
Michael L Edwards
David M Stemerick
Esa T Jarvi
Nellikunja J Prakash
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI894546A0 publication Critical patent/FI894546A0/fi
Publication of FI894546A publication Critical patent/FI894546A/fi
Application granted granted Critical
Publication of FI94763B publication Critical patent/FI94763B/fi
Publication of FI94763C publication Critical patent/FI94763C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI894546A 1988-09-27 1989-09-26 Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi FI94763C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US24991188 1988-09-27
US38939189A 1989-08-03 1989-08-03
US38939189 1989-08-03

Publications (4)

Publication Number Publication Date
FI894546A0 true FI894546A0 (fi) 1989-09-26
FI894546A FI894546A (fi) 1990-03-28
FI94763B FI94763B (fi) 1995-07-14
FI94763C FI94763C (fi) 1995-10-25

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894546A FI94763C (fi) 1988-09-27 1989-09-26 Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0365849B1 (fi)
JP (1) JP2968002B2 (fi)
KR (1) KR0146333B1 (fi)
CN (1) CN1046334A (fi)
AR (1) AR248283A1 (fi)
AT (1) ATE111477T1 (fi)
AU (1) AU621664B2 (fi)
CA (1) CA1336903C (fi)
DE (1) DE68918215T2 (fi)
DK (1) DK171237B1 (fi)
ES (1) ES2063796T3 (fi)
FI (1) FI94763C (fi)
HU (1) HU204843B (fi)
IE (1) IE63561B1 (fi)
IL (1) IL91773A (fi)
NO (1) NO171857C (fi)
NZ (1) NZ230766A (fi)
PT (1) PT91803B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
CA2133961C (en) * 1992-05-12 1998-03-31 James R. Mccarthy A process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
CA2375383C (en) 1999-06-09 2008-07-29 Anticancer, Inc. Modulators of methylation for control of bacterial virulence
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
NZ534811A (en) * 2002-02-14 2007-07-27 Pharmasset Inc Modified fluorinated nucleoside analogues
AP2014007796A0 (en) 2011-12-22 2014-07-31 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
ATE124702T1 (de) * 1987-03-19 1995-07-15 Yamasa Shoyu Kk 2'-alkyliden-pyrimidin-nukleosid-derivate, verfahren zur herstellung und verwendung.
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
FI94763C (fi) 1995-10-25
DE68918215T2 (de) 1995-02-02
KR900004736A (ko) 1990-04-12
HU204843B (en) 1992-02-28
JPH02160769A (ja) 1990-06-20
IL91773A0 (en) 1990-06-10
ATE111477T1 (de) 1994-09-15
JP2968002B2 (ja) 1999-10-25
KR0146333B1 (ko) 1998-08-01
AU4176089A (en) 1990-04-05
EP0365849A3 (en) 1990-12-27
IL91773A (en) 1994-02-27
FI94763B (fi) 1995-07-14
ES2063796T3 (es) 1995-01-16
EP0365849A2 (en) 1990-05-02
NO893826L (no) 1990-03-28
AR248283A1 (es) 1995-07-12
HUT50844A (en) 1990-03-28
PT91803B (pt) 1995-05-31
DK473289A (da) 1990-03-28
IE63561B1 (en) 1995-05-17
FI894546A (fi) 1990-03-28
CA1336903C (en) 1995-09-05
AU621664B2 (en) 1992-03-19
NO171857C (no) 1993-05-12
DK171237B1 (da) 1996-08-05
NO893826D0 (no) 1989-09-26
DK473289D0 (da) 1989-09-26
PT91803A (pt) 1990-03-30
DE68918215D1 (de) 1994-10-20
NZ230766A (en) 1992-07-28
IE893080L (en) 1990-03-27
EP0365849B1 (en) 1994-09-14
CN1046334A (zh) 1990-10-24
NO171857B (no) 1993-02-01

Similar Documents

Publication Publication Date Title
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI893520A (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI891538A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
FI882945A (fi) Menetelmä korkeaa verenpainetta alentavien ja rytmihäiriöitä vastustavien trans-2,2-dimetyylikroman-3-olijohdannaisten valmistamiseksi
FI892182A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI894546A0 (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
FI861987A0 (fi) Piperidylideeni dihydrodibentso/a,d/syklohepteenien ja niiden atsajohdosten valmistusmenetelmä
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
FI902727A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
FI98811B (fi) Menetelmä immuunijärjestelmään vaikuttavien bentseenijohdannaisten valmistamiseksi
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI891111A0 (fi) Menetelmä 1,4-dihydropyridiinijohdannaisten valmistamiseksi
FI93442B (fi) Menetelmä uusien kysteiinijohdannaisten valmistamiseksi
FI96693C (fi) Menetelmä uusien, kasvaimia estävinä aineina käyttökelpoisten 3'-(4-morfolinyyli)- ja 3'-(2-metoksi-4-morfolinyyli)-antrasykliinijohdannaisten valmistamiseksi
FI901550A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten di-imidatsopyrimidiini- ja imidatsopyratsolopyrimidiinijohdannaisten valmistamiseksi
HU8902302D0 (en) Process for preparation of 1,2-hydroxy-phosphonates and derivatives thereof
FI893250A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-diatsepiinijohdannaisten valmistamiseksi
FI900098A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
FI931891A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 7,8-dihydroksi-1H-imidatso- ja pyratsolo/3,4-f/kinoksaliinijohdannaisten valmistamiseksi
DE68920493T2 (de) Verfahren zur Herstellung von Derivaten von 2'-Deoxy-beta-cytidin und Salze davon.
FI892291A (fi) Menetelmä lääkeaineina käyttökelpoisten 6-fenoksimetyyli-4-hydroksitetrahydropyran-2-onien ja 6-tiofenoksimetyyli-4-hydroksitetrahydropyran-2-onien sekä vastaavien dihydroksikarboksyylihappojohdannaisten, suolojen ja estereiden valmistamiseksi
FI885985A (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
FI885033A0 (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
FI903604A0 (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi
FI96606C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-etinyylisytidiini-, uridiini- ja guanosiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: MERRELL DOW PHARMACEUTICALS INC.

MA Patent expired